Apollon Funding & Investors

Cambridge, MA

Apollon offers more simple diagnostic techniques. It can detect inflammatory substances in a single blood sample and measure blood sugar without collecting blood. All of this is possible because light can unlock the signal of chemical bonds in molecules without hurting even the most fragile analytes. To achieve such an ambitious goal, we've gathered a proven team and collaborated with world-class experts from Asan Medical Center, MIT and Harvard Medical School. It is important to note that Apollon is not limited to a single type of biomedical technology. We believe that by keeping an open mind about what is possible, we will be able to achieve the best results for patients all around the world. Apollon was founded in 2021 by an experienced healthcare entrepreneur, as well as medical engineers and clinicians. We have R&D and business operations in Seoul and the Greater Boston area (in process), and we are looking for experts who share our vision for the future. The essence of digital healthcare is to minimize travel so that you can receive clinical help whenever and wherever you need it. Diagnostics that require additional processing will have no place in the future.